Your Prostrate.com logo
Google
Web yourprostate.com.au

Prostate News Archive

22-Nov-2007

  • Obesity can fool prostate exams (The News & Observer)

    The standard screening for prostate cancer might miss cancers in obese men because the protein that signals problems is often wrongly interpreted as low, new research out of Duke University Medical Center reports.


  • Obesity can skew key prostate cancer test results (Reuters via Yahoo! News)

    Doctors reading the results of a blood test widely used to screen for prostate cancer can be fooled into thinking obese men are disease-free, researchers said on Tuesday.


  • Screening tests may miss prostate cancer in obese patients (KARE 11 Minneapolis-St. Paul)

    Higher blood volumes probably cause lower concentrations of prostate-specific antigen, or PSA, in obese prostate cancer patients, reports a study today, leading the


  • Effect Of α1-Adrenoceptor Antagonist Exposure On Prostate Cancer Incidence: An Observational Cohort Study (Medical News Today)

    UroToday.com- In the November issue of the Journal of Urology, Dr. Harris and associates report that the use of alpha-1-adrenorecoptor antagonist's terazosin, prazosin, and doxazosin decrease the incidence of prostate cancer (CaP). Terazosin and doxazosin are used in the treatment of BPH and hypertension. [click link for full article]


  • The Key to Prostate Cancer? Early Detection -- ThirdAge (ThirdAge)

    The Key to prostate Cancer? Early Detection Many men are reluctant to talk about or be checked for prostate cancer, but John Wyatt said early discovery saved his life.


  • Back to Prostate News Archive